Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Regulated PTEN expression to overcome barriers to corticospinal tract regeneration after spinal cord injury

Award Number: R01NS132773
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2029

Group Awards By:

View Award Description

Regulated PTEN expression to overcome barriers to corticospinal tract regeneration after spinal cord injury - Project Summary: 30 lines of text (Currently 28): Spinal cord injuries (SCI) disrupt the communication pathways in the spinal cord, leading to paralysis, primarily affecting the corticospinal tract (CST) responsible for voluntary movements. Unfortunately, damaged CST axons have limited regrowth capacity due to intrinsic and extrinsic factors. Efforts to address intrinsic factors have focused on targeting proteins like PTEN, which inhibits neuronal growth. In addition, there has been a focus on targeting extrinsic molecules such as chondroitin sulfate proteoglycans (CSPGs) through chondroitiase ABC (chABC) digestion, which hinder axon growth. Despite progress in individually targeting these factors, overall growth remains limited, posing a significant challenge. Adeno-associated virus (AAV)- based delivery of growth-promoting molecules has shown promise, but permanent expression can have off- target effects. Our recent findings demonstrated that permanent AAV-driven PTEN deletion resulted in significant functional recovery after SCI, albeit with pathophysiology at 2 months post-SCI. The long-term goal of this project is to develop effective therapeutic strategies for SCI by evaluating controlled PTEN deletion and CSPGs degradation in promoting axon regeneration and functional recovery. The following three specific aims are proposed: 1) Temporal evaluation of PTEN knockdown after SCI without development of pathophysiologies; 2) Determine the role of CST in PTEN-deletion induced recovery of function; 3) Examine the role of CSPGs in growth impairment of PTEN deleted axons. For the first aim, our approach involves regulating PTEN deletion using a regulatory system within our AAVs. This system enables the activation of PTEN deletion in the presence of an inducer drug, enabling us to pinpoint the crucial temporal window for CST regeneration while avoiding the development of pathophysiologies. In the second aim, our approach is to interrupt PTEN-deleted CSTs to assess the extent to which CST regeneration contributes to the observed recovery of function in PTEN-deleted mice after SCI. Lastly, for the third aim, our approach entails testing whether CSPGs are the main impediment for the growth of PTEN-deleted axons by temporally regulating the digestion of CSPGs using chondroitinase ABC (chABC). The proposed studies are innovative as they aim to determine the optimal timing for PTEN deletion to maximize regeneration while avoiding adverse effects, investigate the mechanistic link between PTEN deletion in the CST and functional recovery, and examine the role of CSPGs in inhibiting axonal growth of PTEN-deleted axons. This project is significant as it addresses the critical challenge of limited axon regeneration following spinal cord injury and seeks to identify effective strategies for promoting functional recovery. The completion of the proposed research will establish new knowledge and approaches to enhance axon regeneration and improve outcomes for individuals with SCI.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $391,250 )
2026	2026	UNIVERSITY OF LOUISVILLE	2301 S 3RD ST	LOUISVILLE	KY	40208	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	8/5/2026	NON-COMPETING CONTINUATION	$391,250
														Subtotal = $391,250

Issue Date FY: 2025 ( Subtotal = $391,250 )
2025	2025	UNIVERSITY OF LOUISVILLE	2301 S 3RD ST	LOUISVILLE	KY	40208	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	8/15/2025	NON-COMPETING CONTINUATION	$391,250
2025	2024	UNIVERSITY OF LOUISVILLE	2301 S 3RD ST	LOUISVILLE	KY	40208	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	1	9/18/2025	NEW	$0
														Subtotal = $391,250

Issue Date FY: 2024 ( Subtotal = $391,250 )
2024	2024	UNIVERSITY OF LOUISVILLE	2301 S 3RD ST	LOUISVILLE	KY	40208	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	8/26/2024	NEW	$391,250
														Subtotal = $391,250

Grand Total All Awards = $1,173,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Regulated PTEN expression to overcome barriers to corticospinal tract regeneration after spinal cord injury

Award Number: R01NS132773

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer